ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_43 # 48838 # 49029 # -1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.479	scaffold_1_43 	48838	49029	-	Strict	1500	21.1718	rphB	100.0	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGTACTTCCGTGCTAAGAGGACTCCTAGAGGAGAGCGGGGACCTAAGGGTTTTCAGCGAGTGCAGAGAGTTCCAGGGAGGGCCACATTAGGCCAAAGTGACCCATTACCTTACAGCTATATTCATAACGTCAGTGCTTACAGAGCGCTTTACGGTAAGAGAGAAACATTCCCGGGAATTGTATATATTTGA	MYFRAKRTPRGERGPKGFQRVQRVPGRATLGQSDPLPYSYIHNVSAYRALYGKRETFPGIVYI	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	7.13	gnl|BL_ORD_ID|2297|hsp_num:0	2528	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_1987 # 1946765 # 1946908 # 1 # ID=1_1987;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.507	scaffold_1_1987 	1946765	1946908	+	Strict	1200	21.1718	LRA-13	100.0	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	ATGCGTGCGTGTGGAGAGGATTATGCTAATATAAAACAGATCGTCATGCCTGAAGTTGTGGTTGTGGAAAAGTTGGAGGAGAGTGTAAGAGGTGCTGGAGGATTCGGGAGTACCGGCGGGTTCGGGGCCGGAAAGACAGCATAA	MRACGEDYANIKQIVMPEVVVVEKLEESVRGAGGFGSTGGFGAGKTA	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	7.72	gnl|BL_ORD_ID|1806|hsp_num:0	1912	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_2345 # 2296211 # 2296348 # 1 # ID=1_2345;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.464	scaffold_1_2345 	2296211	2296348	+	Strict	2000	20.4014	Staphylococcus aureus mupB conferring resistance to mupirocin	100.0	3000510	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGTCGCTAATCGAGGTTACTAATAATTTCTACCCATTTTGCTGGATTATAAACGTCGAGTCTTGCAATCGCCAACATGGCGAAGAAGAAGAGCAAGAAGAACAACCAGAAGCAGGTGGATGTCGCGCCCCCTCCTGA	MSLIEVTNNFYPFCWIINVESCNRQHGEEEEQEEQPEAGGCRAPS	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	4.36	gnl|BL_ORD_ID|2124|hsp_num:0	2271	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_668 # 630199 # 630399 # -1 # ID=2_668;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.527	scaffold_2_668 	630199	630399	-	Strict	577	21.1718	SHV-220	100.0	3005224	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGCGCGATTGCACTGCAAATCGGTCAGTCTGCTTTCTCGACATTGCAAGCGACAAAGAGCTTACAAATTGGCACTTGTATTTCTTGTCGGGCACTTTAGCACCGGCAGGCCTTGCGTTCGACGCCATTTGGATGGTTGACGATGGTGTTGAGTCGAGGCGCGTGGTGTTAAAGTGCGAAGGTCGTGGGCGTGGGTGGTGA	MRDCTANRSVCFLDIASDKELTNWHLYFLSGTLAPAGLAFDAIWMVDDGVESRRVVLKCEGRGRGW	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSPRLSVRSQRQLLQWMVDDGVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	23.08	gnl|BL_ORD_ID|2986|hsp_num:0	3946	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_3110 # 3017171 # 3017413 # -1 # ID=2_3110;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.572	scaffold_2_3110 	3017171	3017413	-	Strict	540	21.557	OXA-279	100.0	3001734	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGAGGCCACCGCCAAGGCTGATCTACGGCGCGACAACACCCCCGGGCTCACTGGGGGTGGCTTGAAGAAGTCTTCCTTTCCGAAATTCGCATACGCCCTTGCGCATCCTCTTCGCGATGGGCTGCGGTCTGTCTTTGGTGGGGCACAGCCTTCAAAGAGGCCCGCTGCCGGTGGCAATACATTCCTCATTCTGGATGAACGGACACAAAGGAACAAAGGAGCTTTGGGAGCAGTATGTTGA	MEATAKADLRRDNTPGLTGGGLKKSSFPKFAYALAHPLRDGLRSVFGGAQPSKRPAAGGNTFLILDERTQRNKGALGAVC	MPKILKHLGLCASVMIGLTLLGCQNLQAPTQSAVSKKHDQTEIASLFQHAQTVGVFVTYDGQTLQEYGNALSRSNTAYIPASTFKMLNALIGIQHHKSSPNEVFKWDGKKRAFASWEKDLTLAEAMQASAVPVYQELARRIGLELMANEVKRVGFGNAEIGTQVDDFWLVGPLKITPVEEVKFAYALAHKQLTFDQSVQEQVKQMVLVDEVKGTKIYAKSGWGMDVTPQVGWWTGWIEQPNGQVIAFSLNMQINNSKQGDARKAIVYQALQQLKLLETQ	28.67	gnl|BL_ORD_ID|2659|hsp_num:0	3444	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_1335 # 1357037 # 1357171 # -1 # ID=3_1335;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.541	scaffold_3_1335 	1357037	1357171	-	Strict	2300	22.3274	evgS	100.0	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGACGATCACCCGACGAATCGTGCTGGGAGGCCCAAGGACATCGCGGATGCCGCACTGTATCTGATTGATGCTGGTTTCATCACGGGTCAAGATATAACAGTGGATGGCGGAGCGCTGAGGAAGAAGCACTAA	MDDHPTNRAGRPKDIADAALYLIDAGFITGQDITVDGGALRKKH	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	3.68	gnl|BL_ORD_ID|1243|hsp_num:0	1318	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_1620 # 1637032 # 1637157 # 1 # ID=3_1620;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.548	scaffold_3_1620 	1637032	1637157	+	Strict	400	20.7866	Erm(42)	100.0	3003106	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGTCATCTTCGGCGACATCTCCCCAAGGGCAAGAAGGAGGTTGTTAGGAGGGGCGGATAGGAAGCTTGTTGGGTACATGGGGGTGAAGGAGGAAGAATGTGGAGAGGATAGGCATGCCTGGTGA	MVIFGDISPRARRRLLGGADRKLVGYMGVKEEECGEDRHAW	MNKNTKIKNKNFNIKDSQNFLHNTKLVEDLLFKSNITKEDFVVEIGPGKGIITKALSKICKAVNAIEFDSVLADKLSHEFKSSNVSIIEADFLKYNLPDHNYKVFSNIPFNITASILNKLLDSENPPLDTFLIMQYEPFLKYAGAPSYKESYKSLLYKPFFKTNILHSFSKFDFKPAPNANIILGQFSYKDFTDINLEDRHAWKDFLAFVFLEKGVTFKEKTKRIFSYKQQKIILKESRINDDSNISNWSYEFWLKMFKLYNSNMVSKDKKVLVNNSYKRMLEHESSLEKIHRNRKQNNRK	13.62	gnl|BL_ORD_ID|656|hsp_num:0	697	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_1032 # 968984 # 969136 # -1 # ID=4_1032;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.451	scaffold_4_1032 	968984	969136	-	Strict	550	20.4014	LRA-3	100.0	3002510	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGTTTTTTTTAGATGGTCAGGGTAACCGCCGCCTCACGTCATCCCCGTTATCGATAGCCGACATCGGCATTATCTCCGTTGCATACTCATACACTTGTGACATCAATTCGGGTGCTGACGGCAGTTGTGATTATACATCATTCGTATCCTAA	MFFLDGQGNRRLTSSPLSIADIGIISVAYSYTCDINSGADGSCDYTSFVS	MKSKLLLAAALAALAGTSMAAQAAELQYKPPPITNKEWETPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILINSGADGSYPLIKANIEKLGFKTSDIKIITSTHGHGDHVGDLAAFQKDAPAAKTYMNFRDAPTIESGGNIDYRRPEGRGFYPYHPVKVDVRTKPGDHIKLGNTDLTLHQAYGHTPGATSFTFTVQDGGRNYNVLIVNMNGINAGVKLLGSPGYPTIVEDFASTLKEQATYTPDLWVSSHAGQFNLHQVYKPGDPYNPARFGDLAAYKLKIANATKAYEKQLAEERAAKAK	16.56	gnl|BL_ORD_ID|1938|hsp_num:0	2055	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_2037 # 2003200 # 2003439 # 1 # ID=4_2037;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.525	scaffold_4_2037 	2003200	2003439	+	Strict	400	21.557	Erm(38)	100.0	3000601	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGTTGAATGTGAATGTGTCGTTATGGACAGGGAGCGTGGGTCTGACGATGGACTGCTATTTGCATGGACCAGGGTGGATGGATGTTCGGTCGGGTGTGGCGTGTTTGTCCGTGTGTGGTGCATGTGTCAAGAAGAGCAAACTCAAGGCTGGTCAAGTTGAGGTGCAGTGTCTACCTGTCGCCTCAACTGGGTATGTCTTCGCCTCAACTAGGTCTGGGTATGCAGAAGCTAGGTGTTGA	MLNVNVSLWTGSVGLTMDCYLHGPGWMDVRSGVACLSVCGACVKKSKLKAGQVEVQCLPVASTGYVFASTRSGYAEARC	MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAVEVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRRLLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKARVNGPTPPGLGDT	20.47	gnl|BL_ORD_ID|1030|hsp_num:0	1097	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_2195 # 2145683 # 2145946 # 1 # ID=4_2195;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.530	scaffold_4_2195 	2145683	2145946	+	Strict	500	22.3274	erm(46)	100.0	3004596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGGAGGGCGAAGTTGTAATATGAGGATAAGATCTCTGGAGAATACAGTAGCATTTGATACGATCGTACTTCAGATGTTGGACTGGGATGTCCAGTGGTGGCCATGGGGCGCAACCCTGGAAGCTGTGGAACCACTTAGAGTCACGTGCTCATGTGTCAGGCAGGTTTCGCGCGCGCGCAACAAGTTGAAAATCAGGGACGAAGTTGTCAGGGCGCAATGCATGACATCAACCGGCGGCACAACGGCGTCCGTGTCGCTGTAA	MGGRSCNMRIRSLENTVAFDTIVLQMLDWDVQWWPWGATLEAVEPLRVTCSCVRQVSRARNKLKIRDEVVRAQCMTSTGGTTASVSL	MPTYRSGRHELGQNFLTDRKAVDTIVDLVSRTDGPIIEIGSGGGALTLPLQALRRPITAIEIDPRHVQKLQHRVDPSTTVVHGDFLRYRLPRTPHTIVGNLPFHHTTAMLRRILHAEHWTASVLLVQWEVARRRAAVGGATMMTAQWWPWYDFGLAGRVSASAFTPRPGVDAGLMTIARRTVPLVDPALRPRYSTFVHTVFTSKGHGLHQILPRVAGDPEKAAVKKWLAGQRFRGTPLPRDLSPGQWSELFAIIDRRSPATDRKRAEYRR	32.22	gnl|BL_ORD_ID|2788|hsp_num:0	3297	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_2358 # 2301251 # 2301430 # -1 # ID=4_2358;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.539	scaffold_4_2358 	2301251	2301430	-	Strict	1150	20.7866	blaR1	100.0	3000217	protein homolog model	n/a	n/a	penam	antibiotic inactivation	blaZ beta-lactamase	ATGCCACGACTGTATCACCACGGGACTGATTGTGCTGCAGGTGCCGACAACGTGGAAGCGGCGCTATGCTTCTACCGCGCCTTGAAGGTGTACCCCAACCCACGAGAGCTCATCAACATTTACGACAAGACTGTCCCCAAGGCAAGACATGTTCCTTCCTTTTTTGACCAAGGCCGCTAA	MPRLYHHGTDCAAGADNVEAALCFYRALKVYPNPRELINIYDKTVPKARHVPSFFDQGR	MTLPHILLSLVLITATILVIFFVRAVFYKQLSAKWRYHLWFLLITVLTLPFIPIHLLTGLSFFDQGRQQITPSAQKRFGFADQNEQWMVDFGTSVSRFDDTFIHAVFVSIWIGGMIFFLLLTLYHYAKLQRLVKAASRIQNQKVENAFSDCMAELQITNKLTNLESPAIQTPMTFGWLKTYILLPKNIELYLSDDEIRHVLLHELHHYKSKHIKVNYIFVVYQIVYWFHPLVWKAFKEMRLDRELACDTEVLLTLGQREYKAYGQTIMRFLERNSRFLYLTNPLHSSKKAFKNTKSYNIAFFYWRVKSGAQLKKPWVVFAGLTRFCIAQFPFLTATAVSTERYQFDESQAVVEDYSTYFAGNEGSFVLYSLTSDQFEIYNKEKSVRRVSPNSSYKIYTALMALELGVIGRDDSWLEWDGVEYEDEAWNSGQDLKSAMSQSVTWYFQELDERIKQRNIQSFVNQLDYGNKDLSGGLNHYWLESSLKISPVEQVELLHSFYTNQLDFKEEHVQFVKEVMKLEENQKGTLYGKTGTGIVNGHAINGWFIGFVETETDTYFFATNIQQKIMHMEARLLKSLYPFCQAKEFID	10.03	gnl|BL_ORD_ID|1946|hsp_num:0	2063	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_517 # 497719 # 497841 # 1 # ID=12_517;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.537	scaffold_12_517 	497719	497841	+	Strict	600	20.7866	ICR-Mc	100.0	3004466	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGCGCGATGGTGCAGCAATGGATGTGGGGAGTTGGGAGTGCTATGGAGATCCAGACGAGCACCAGTCATGCTCAATGCGGACGGGCAGCAACTCCTTCTGGTCCAAGATTGCAACACTTTAA	MRDGAAMDVGSWECYGDPDEHQSCSMRTGSNSFWSKIATL	MSLKHNQTHNTTFTKFLKSNSFWSKGFWSNRHHRTKDLKGLDAYLFMAIVAIFLTTTANVTFFQQVMSVYPLANYAPFIASLAVVLTGVLLLLLVLLGYRHTLKTVAICFILIAAFAGHFTDTYGTVYDTTMLQNALQTDTAETKDLLSMKLLIRVVLLAGLPICWIIGQPLSFGTLKASLMKRLVTYLVALALVGLPILAFSSQYASFFREHKPLRFFTNPVTVMYSAGKLANMSYKNATKPTETIMHANDAIQKTTASTRKPRLVVMVVGETARADHASFNGYQRATFPHMDKLIGLGQVHNFGNVTSCGTSTAYSVPCMFSYLGAEKYDVDTADYHENVIDTLDRLGVAILWRDNNSDSKGVMNRLPAKQYQDYKNSPLQGGNNTICHTNPYDECRDVGMLVDLDDHVKAHANQDILIVLHQMGNHGPAYYKRYDDEFAQFLPVCTSSELAECERQTVINAYDNALLATDDFLKQTIDWLAAQTHADTAMLYLSDHGESLGEKGVYLHGMPKAFAPKEQLSIPALLWLGADTPFAVANSPTAGFSHDAITPTLLNLFDVSTQATADKTAFVNPLD	6.92	gnl|BL_ORD_ID|2575|hsp_num:0	2902	True	loose hit with at least 95 percent identity pushed strict
scaffold_13_1139 # 1133850 # 1133966 # 1 # ID=13_1139;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.538	scaffold_13_1139 	1133850	1133966	+	Strict	2300	20.0162	evgS	100.0	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGAGTCAGCTGCAGCCACAGTGGAAGCAGGATTCTTTGCTCACTGATTCCGTGAGGGTCAGGTCCCCATCTGTCGCCGCTGGTACCGTTGCATGCGGGTTGATTTTCATGTAA	MESQLQPQWKQDSLLTDSVRVRSPSVAAGTVACGLIFM	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	3.17	gnl|BL_ORD_ID|1243|hsp_num:0	1318	True	loose hit with at least 95 percent identity pushed strict
scaffold_28_57 # 65790 # 65963 # 1 # ID=28_57;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.454	scaffold_28_57 	65790	65963	+	Strict	1000	21.9422	eptA	100.0	3003576	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACTATTGCCGCTGCCAGCGGAGCAAAGGGTGACGAGGTCTTGTTTCACGGTCTTTCAGCATCTGGTACTTTGGTGGCTCAACGTACATCACATACTCTGGCAAGCTATACAGAAGCCAGAAACTTCTATGGCATATTACGTTATGTTATATCAGACTTGAGAAGCGAATGA	MTIAAASGAKGDEVLFHGLSASGTLVAQRTSHTLASYTEARNFYGILRYVISDLRSE	MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFSVINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALMTPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVLFHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE	10.42	gnl|BL_ORD_ID|611|hsp_num:0	516	True	loose hit with at least 95 percent identity pushed strict
scaffold_28_62 # 68202 # 68399 # 1 # ID=28_62;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.490	scaffold_28_62 	68202	68399	+	Strict	500	21.9422	cmrA	100.0	3002702	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCATCGCGCCAATTCGCGGGGCGCACGCGATGGATTCGGCTCGTGTTTCATGATACGAGAAATATGGGGATGGAGATTTAGTCATGGTCAATACGCAGGAAGAGTCAAGATCAGAAGGATGCGCGAGTGGAATCTCGAAGATGAGGTGAAAAGAAGATTGCATGTTGTCTCGTATGCGAGAGTAGTCCTGGATTGA	MHRANSRGARDGFGSCFMIREIWGWRFSHGQYAGRVKIRRMREWNLEDEVKRRLHVVSYARVVLD	MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAIASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA	16.62	gnl|BL_ORD_ID|1644|hsp_num:0	1744	True	loose hit with at least 95 percent identity pushed strict
